413 related articles for article (PubMed ID: 2663884)
1. Characterization of transforming growth factors produced by the insulin-independent teratoma-derived cell line 1246-3A.
Yamada Y; Serrero G
J Cell Physiol; 1989 Aug; 140(2):254-63. PubMed ID: 2663884
[TBL] [Abstract][Full Text] [Related]
2. Decreased transforming growth factor-beta response and binding in insulin-independent teratoma-derived cell lines with increased tumorigenic properties.
Serrero G; Zhou J; Mills D; LePak N
J Cell Physiol; 1991 Dec; 149(3):503-11. PubMed ID: 1660484
[TBL] [Abstract][Full Text] [Related]
3. Effect of testosterone on the growth properties and on epidermal growth factor receptor expression in the teratoma-derived tumorigenic cell line 1246-3A.
Serrero G; Lepak NM; Hayashi J; Eisinger DP
Cancer Res; 1992 Aug; 52(15):4242-7. PubMed ID: 1638538
[TBL] [Abstract][Full Text] [Related]
4. Growth stimulation, altered regulation of epidermal growth factor receptors, and autocrine transformation of spontaneously transformed normal rat kidney cells by transforming growth factor beta.
Nugent MA; Lane EA; Keski-Oja J; Moses HL; Newman MJ
Cancer Res; 1989 Jul; 49(14):3884-90. PubMed ID: 2786745
[TBL] [Abstract][Full Text] [Related]
5. [Growth factors produced by rat glioma cells: activities of transforming growth factors].
Kanno H; Shinonaga M; Kuwabara T; Umeda M
No To Shinkei; 1989 Sep; 41(9):905-9. PubMed ID: 2590559
[TBL] [Abstract][Full Text] [Related]
6. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha.
Ethier SP; Langton BC; Dilts CA
Mol Carcinog; 1996 Feb; 15(2):134-43. PubMed ID: 8599580
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of epidermal growth factor/transforming growth factor-alpha-stimulated cell growth by a synthetic peptide.
Eppstein DA; Marsh YV; Schryver BB; Bertics PJ
J Cell Physiol; 1989 Nov; 141(2):420-30. PubMed ID: 2530243
[TBL] [Abstract][Full Text] [Related]
8. Purification and biological properties of type beta transforming growth factor from mouse transformed cells.
Fernandez-Pol JA; Klos DJ; Grant GA
Cancer Res; 1986 Oct; 46(10):5153-61. PubMed ID: 3489522
[TBL] [Abstract][Full Text] [Related]
9. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells.
Salomon DS; Perroteau I; Kidwell WR; Tam J; Derynck R
J Cell Physiol; 1987 Mar; 130(3):397-409. PubMed ID: 3494020
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factors produced by normal and neoplastically transformed rat liver epithelial cells in culture.
Liu C; Tsao MS; Grisham JW
Cancer Res; 1988 Feb; 48(4):850-5. PubMed ID: 3276400
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic transformation of normal rat kidney cells in a growth-factor-defined medium: induction by a neuroblastoma-derived transforming growth factor independently of the EGF receptor.
van Zoelen EJ; van Oostwaard TM; van der Saag PT; de Laat SW
J Cell Physiol; 1985 May; 123(2):151-60. PubMed ID: 2984216
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor I and transforming growth factor alpha as autocrine growth factors in human pancreatic cancer cell growth.
Ohmura E; Okada M; Onoda N; Kamiya Y; Murakami H; Tsushima T; Shizume K
Cancer Res; 1990 Jan; 50(1):103-7. PubMed ID: 2152769
[TBL] [Abstract][Full Text] [Related]
13. Presence of growth factors in human pituitary.
Halper J; Parnell PG; Carter BJ; Ren P; Scheithauer BW
Lab Invest; 1992 May; 66(5):639-45. PubMed ID: 1573857
[TBL] [Abstract][Full Text] [Related]
14. Production of transforming growth factors by human colon cancer lines.
Coffey RJ; Shipley GD; Moses HL
Cancer Res; 1986 Mar; 46(3):1164-9. PubMed ID: 3002610
[TBL] [Abstract][Full Text] [Related]
15. [A transforming growth factor-beta like growth factor in mouse embryonal carcinoma cells].
Shi WK; Yao Z
Shi Yan Sheng Wu Xue Bao; 1989 Jun; 22(2):213-23. PubMed ID: 2800839
[TBL] [Abstract][Full Text] [Related]
16. [The effect of the beta-type transforming growth factor and its combination with epidermal growth factor and insulin on substrate-dependent proliferation of normal and tumor cells].
Sushel'nitskiĭ SI; Stoĭka RS; Garas'ko SI; Shafranskaia GI; Kusen' SI
Tsitologiia; 1989 Jul; 31(7):767-74. PubMed ID: 2683271
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.
Arteaga CL; Tandon AK; Von Hoff DD; Osborne CK
Cancer Res; 1988 Jul; 48(14):3898-904. PubMed ID: 3164252
[TBL] [Abstract][Full Text] [Related]
18. Mouse Balb/c3T3 cell mutant with low epidermal growth factor receptor activity: induction of stable anchorage-independent growth by transforming growth factor beta.
Kuratomi Y; Ono M; Yasutake C; Mawatari M; Kuwano M
J Cell Physiol; 1987 Jan; 130(1):51-7. PubMed ID: 3468117
[TBL] [Abstract][Full Text] [Related]
19. Human A673 cells secrete high molecular weight EGF-receptor binding growth factors that appear to be immunologically unrelated to EGF or TGF-alpha.
Stromberg K; Hudgins WR; Fryling CM; Hazarika P; Dedman JR; Pardue RL; Hargreaves WR; Orth DN
J Cell Biochem; 1986; 32(4):247-59. PubMed ID: 3492500
[TBL] [Abstract][Full Text] [Related]
20. Infection with a TGF-alpha retroviral vector transforms normal mouse mammary epithelial cells but not normal rat fibroblasts.
McGeady ML; Kerby S; Shankar V; Ciardiello F; Salomon D; Seidman M
Oncogene; 1989 Nov; 4(11):1375-82. PubMed ID: 2812779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
